G. Sponer

1.3k total citations
63 papers, 1.0k citations indexed

About

G. Sponer is a scholar working on Cardiology and Cardiovascular Medicine, Cancer Research and Surgery. According to data from OpenAlex, G. Sponer has authored 63 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 12 papers in Cancer Research and 10 papers in Surgery. Recurrent topics in G. Sponer's work include Protease and Inhibitor Mechanisms (12 papers), Blood Pressure and Hypertension Studies (10 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). G. Sponer is often cited by papers focused on Protease and Inhibitor Mechanisms (12 papers), Blood Pressure and Hypertension Studies (10 papers) and Blood Coagulation and Thrombosis Mechanisms (8 papers). G. Sponer collaborates with scholars based in United States, Germany and Switzerland. G. Sponer's co-authors include K. Strein, W. Bartsch, B. Müller‐Beckmann, Ulrich Martin, Detlev Ganten, P. Schelling, Ursula Ganten, Η Böhm, Stephan Fischer and T Unger and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

G. Sponer

61 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Sponer United States 18 490 216 214 112 94 63 1.0k
H. Neubauer Germany 21 553 1.1× 153 0.7× 301 1.4× 82 0.7× 84 0.9× 74 1.3k
T D Bjornsson United States 16 333 0.7× 159 0.7× 158 0.7× 52 0.5× 104 1.1× 23 979
Hideki Shimomura Japan 20 432 0.9× 257 1.2× 303 1.4× 52 0.5× 103 1.1× 77 1.3k
Takaatsu Kamada Japan 16 579 1.2× 216 1.0× 156 0.7× 179 1.6× 68 0.7× 25 1.1k
Mitsumasa Fukuchi Japan 14 637 1.3× 258 1.2× 128 0.6× 87 0.8× 33 0.4× 24 1.0k
R De Caterina Italy 17 720 1.5× 185 0.9× 215 1.0× 42 0.4× 70 0.7× 54 1.3k
Alexander Breitenstein Switzerland 21 565 1.2× 262 1.2× 341 1.6× 68 0.6× 89 0.9× 116 1.6k
G. Riegger Germany 21 579 1.2× 250 1.2× 271 1.3× 55 0.5× 26 0.3× 56 1.4k
B. McArdle United Kingdom 19 203 0.4× 279 1.3× 157 0.7× 33 0.3× 113 1.2× 39 963
Jan‐Arne Björkman Sweden 16 522 1.1× 240 1.1× 179 0.8× 29 0.3× 104 1.1× 38 919

Countries citing papers authored by G. Sponer

Since Specialization
Citations

This map shows the geographic impact of G. Sponer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Sponer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Sponer more than expected).

Fields of papers citing papers by G. Sponer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Sponer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Sponer. The network helps show where G. Sponer may publish in the future.

Co-authorship network of co-authors of G. Sponer

This figure shows the co-authorship network connecting the top 25 collaborators of G. Sponer. A scholar is included among the top collaborators of G. Sponer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Sponer. G. Sponer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sponer, G., et al.. (2015). Methods for the Measurement of Blood Pressure in Conscious Rats. Contributions to nephrology. 60. 220–229. 1 indexed citations
2.
Sponer, G., et al.. (2011). Wirkungen von Carvedilol auf das Kontrastmittel-Echokardiogramm im Vergleich zu Metoprolol bei wachen Hunden. Arzneimittelforschung. 49(10). 830–834.
3.
Bauss, Frieder, et al.. (2004). New model for simulation of fracture repair in full-grown beagle dogs: Model characterization and results from a long-term study with ibandronate. Journal of Pharmacological and Toxicological Methods. 50(1). 25–34. 38 indexed citations
4.
Sharpe, Norman, et al.. (2001). Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial. International Journal of Clinical Pharmacology and Therapeutics. 39(5). 205–212. 3 indexed citations
5.
Gonschior, P., et al.. (1999). Local drug delivery via transvascular injection.. PubMed. 11(10). 600–7. 1 indexed citations
6.
Sponer, G., et al.. (1996). EFFECTS OF NAFTOPIDIL ON SOME URODYNAMIC PARAMETERS AND ARTERIAL BLOOD PRESSURE IN COMPARISON WITH PRAZOSIN IN CONSCIOUS RATS. Pharmacological Research. 34(3-4). 121–124. 4 indexed citations
7.
Bauss, Frieder, et al.. (1996). Effect of 17β-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17β-estradiol serum kinetics and bone mass in rats. Calcified Tissue International. 59(3). 168–173. 31 indexed citations
8.
9.
Sponer, G., K. Strein, W. Bartsch, & B. Müller‐Beckmann. (1992). Vasodilatory Action of Carvedilol. Journal of Cardiovascular Pharmacology. 19(Supplement 1). S5–S11. 16 indexed citations
10.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1992). Pharmacokinetic and thrombolytic properties of unglycosylated recombinant tissue-type plasminogen activator (BM 06.021) produced in Escherichia coli. Naunyn-Schmiedeberg s Archives of Pharmacology. 346(1). 108–113. 9 indexed citations
11.
12.
Sponer, G., et al.. (1992). Pharmacological profile of ?-adrenoceptor blockers with vasodilating properties, especially carvedilol ? rationale for clinical use. Journal of Molecular Medicine. 70(S2). S20–6. 5 indexed citations
13.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1991). Pharmacokinetic properties of an escherichia-coli-produced recombinant plasminogen activator (BM 06.022) in rabbits. Thrombosis Research. 62(3). 137–146. 14 indexed citations
14.
Martin, Ulrich, Stephan Fischer, Ulrich Kohnert, et al.. (1991). Coronary Thrombolytic Properties of a Novel Recombinant Plasminogen Activator (BM 06.022) in a Canine Model. Journal of Cardiovascular Pharmacology. 18(1). 111–119. 25 indexed citations
15.
Bartsch, W., et al.. (1990). Pharmacological characteristics of the stereoisomers of carvedilol. European Journal of Clinical Pharmacology. 38(S2). S104–S107. 74 indexed citations
16.
Müller‐Beckmann, B., et al.. (1990). Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs. British Journal of Pharmacology. 101(3). 686–690. 8 indexed citations
17.
Sponer, G., et al.. (1984). Pharmacokinetic aspects of isosorbide-5-mononitrate in dogs.. Journal of Pharmacology and Experimental Therapeutics. 228(1). 235–239. 11 indexed citations
18.
Strein, K., et al.. (1984). Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.. Journal of Pharmacology and Experimental Therapeutics. 229(3). 787–792. 4 indexed citations
19.
Sponer, G., et al.. (1981). Hyperfibrinolysis and hypercholesterolaemia in, salt-intoxication in, pigs. Experimental Pathology. 19(3). 137–145. 5 indexed citations
20.
Bartsch, W., et al.. (1977). Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 27(12). 2319–22. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Neubauer Breakdown of academic impact, for papers by T D Bjornsson Breakdown of academic impact, for papers by Hideki Shimomura Breakdown of academic impact, for papers by Takaatsu Kamada Breakdown of academic impact, for papers by Mitsumasa Fukuchi Breakdown of academic impact, for papers by R De Caterina Breakdown of academic impact, for papers by Alexander Breitenstein Breakdown of academic impact, for papers by G. Riegger Breakdown of academic impact, for papers by B. McArdle Breakdown of academic impact, for papers by Jan‐Arne Björkman
Rankless by CCL
2026